News Sentiment

EGTX sentiment intelligence

Egetis Therapeutics AB (publ) news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report RSS feed
Weighted score 50 Balanced news tone 4 relevant articles
Exchange STO Sweden
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 6.08 Week of 10 Jul 2026
Weighted tone 50/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

71/100 classification confidence.

Company focus 4

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend active

+5.7% over one week, +14.1% over four weeks, trend active, and near fair-value range.

Latest direct headline Neutral

Perspective Therapeutics Announces Acceptance of VMT-α-NET Data for Oral Presentation at the ESMO Congress 2026

Market Reaction

Price moving ahead of tone

55/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 71/100 classification
One-week reaction 5.7% Price confirming higher
Trend fit Trend active 14.1% over four weeks
Fair value 13.5% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 0
Neutral 4
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 4
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
GlobeNewswire 1
insights.citeline.com 1
Moomoo 1
Cision News 1

Event Lens

What the news is about

Classified themes
Market update 3
Earnings 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-4 of 4